Inpart is the leading global platform for science partnering. We provide comprehensive solutions to facilitate, optimize and track collaborations across industry and academia. 

In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry.   ​

The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations.   ​

Our commitment to excellence, creativity, and purpose-driven initiatives fuels our mission to connect the right partners at the right time for the purpose of bringing science to the market faster.   ​

Biotechnology

Life Sciences

Pharmaceutical

Inpart

Gilles T.

Baptiste Houlbrèque

Nick Spirit

Martha Clay

Andrea W.

Atsumi Fujigasaki

Freya Damrell

Joachim Eeckhout

Anis Rokbani

Sarah Issa

Patrick S.

Steffina Tagoreraj

Robin K.

Description

People (16)

Gilles T.

Nick Spirit

Karina Isabel Q.

Echo Ao Z.

Pierrick Tassery

Shikha Singh

Samuel A.

Jesus H.

Bertrand Bories

Steffina Tagoreraj

Xavier G.

Antoine Nguyen

Thomas Romanet

Atsumi Fujigasaki

Anis Rokbani

Michelle Tucci

Jobs